• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

LICOCHALCONEC

CAS No. 144506-14-9

LICOCHALCONEC ( Licochalcone C; Licochalcone-C )

产品货号. M18021 CAS No. 144506-14-9

Licochalcone C has potent antioxidant properties and inhibition of bacterial growth and cellular respiration.

纯度: 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥3208 有现货
10MG ¥4771 有现货
25MG ¥7655 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    LICOCHALCONEC
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Licochalcone C has potent antioxidant properties and inhibition of bacterial growth and cellular respiration.
  • 产品描述
    Licochalcone C is an inhibitor of lipopolysaccharide-interferon-γ inflammation. It acts by improving antioxidant conditions and regulating inducible nitric oxide synthase expression. It acts as an inhibitor of recombinant human PTP1B assessed as hydrolysis of p-nitrophenyl phosphate.
  • 同义词
    Licochalcone C; Licochalcone-C
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    Antioxidant
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    144506-14-9
  • 分子量
    338.39
  • 分子式
    C21H22O4
  • 纯度
    98%
  • 溶解度
    ——
  • SMILES
    COc1c(\C=C\C(=O)c2ccc(O)cc2)ccc(O)c1CC=C(C)C
  • 化学全称
    (E)-3-[4-Hydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Zhou M, et al. Life Sciences, 2015, 132:27-33.
产品手册
关联产品
  • Xenopsin

    Xenopsin, a neurotensin-like octapeptide, Xenopsin is an inhibitor of Tetragastrin stimulated gastric acid secretion.

  • Methyl nomilinate

    Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.

  • TT01001

    TT01001 is a selective agonist of mitoNEET and reduces oxidative stress injury and neuronal apoptosis by improving mitochondrial dysfunction. TT01001 can be used in studies about the treatment of type II diabetes.